feed,title,long_url,short_url
gNews,"Acelyrin fails late-phase clinical trial months after $540M IPO, sending stock hurtling downward - FierceBiotech",https://news.google.com/rss/articles/CBMie2h0dHBzOi8vd3d3LmZpZXJjZWJpb3RlY2guY29tL2Jpb3RlY2gvYWNlbHlyaW4tZmFpbHMtbGF0ZS1waGFzZS1jbGluaWNhbC10cmlhbC1tb250aHMtYWZ0ZXItNTQwbS1pcG8tc2VuZGluZy1zdG9jay1odXJ0bGluZ9IBAA?oc=5,https://da.gd/XABa
